NASAL VACCINE Subject: Science & tech Context: Recently, the Central Drugs Standard Control Organisation recommended granting permission for phase 1 human clinical trials for Bharat Biotech’s nasal COVID-19 vaccine, BBV154. Concept: About the Vaccine Bharat Biotech has partnered with Washington University School of Medicine in St Louis for a novel intranasal coronavirus vaccine […]